Your browser doesn't support javascript.
loading
Ocular Manifestations of Neuronal Ceroid Lipofuscinoses.
Singh, Rohan Bir; Gupta, Prakash; Kartik, Akash; Farooqui, Naba; Singhal, Sachi; Shergill, Sukhman; Singh, Kanwar Partap; Agarwal, Aniruddha.
Affiliation
  • Singh RB; Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Gupta P; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kartik A; Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Farooqui N; Department of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
  • Singhal S; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Shergill S; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Singh KP; Department of Anesthesiology, Yale-New Haven Hospital, New Haven, CT, USA.
  • Agarwal A; Department of Ophthalmology, Dayanand Medical College & Hospital, Ludhiana, India.
Semin Ophthalmol ; 36(7): 582-595, 2021 Oct 03.
Article in En | MEDLINE | ID: mdl-34106804
ABSTRACT
Neuronal ceroid lipofuscinoses (NCLs) are a group of rare neurodegenerative storage disorders associated with devastating visual prognosis, with an incidence of 1/1,000,000 in the United States and comparatively higher incidence in European countries. The pathophysiological mechanisms causing NCLs occur due to enzymatic or transmembrane defects in various sub-cellular organelles including lysosomes, endoplasmic reticulum, and cytoplasmic vesicles. NCLs are categorized into different types depending upon the underlying cause i.e., soluble lysosomal enzyme deficiencies or non-enzymatic deficiencies (functions of identified proteins), which are sub-divided based on an axial classification system. In this review, we have evaluated the current evidence in the literature and reported the incidence rates, underlying mechanisms and currently available management protocols for these rare set of neuroophthalmological disorders. Additionally, we also highlighted the potential therapies under development that can expand the treatment of these rare disorders beyond symptomatic relief.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuronal Ceroid-Lipofuscinoses Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Semin Ophthalmol Journal subject: OFTALMOLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuronal Ceroid-Lipofuscinoses Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Semin Ophthalmol Journal subject: OFTALMOLOGIA Year: 2021 Document type: Article Affiliation country: Estados Unidos